Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 155 clinical trials
A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)

The main purpose of this study is to evaluate the safety and tolerability of single dose of treprostinil palmitil inhalation powder (TPIP) in participants with pulmonary arterial hypertension

  • 0 views
  • 24 Jul, 2022
  • 4 locations
A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) (IMPAHCT)

Pulmonary Arterial Hypertension (PAH). The Phase 2b part of the study will assess three doses to establish an optimal dose for the Phase 3 part of the study. The Phase 2b primary endpoint will be the

  • 0 views
  • 12 Jul, 2022
  • 11 locations
Positioning Imatinib for Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension (PAH) is a rare condition in which a narrowing of blood vessels carrying blood through the lungs puts an increased work load on the heart; it has to work harder

  • 0 views
  • 27 Sep, 2021
  • 8 locations
Olaparib for PAH: a Multicenter Clinical Trial (OPTION)

, pulmonary arterial hypertension (PAH), to early-phase clinical trials. We, and others, have published strong evidence that DNA damage accounts for disease progression in PAH and showed that PARP1 inhibition

hysterectomy
pulmonary disease
serum pregnancy test
cancer
body mass index
  • 22 views
  • 09 Jun, 2022
  • 3 locations
Exercise Training in Patients With Pulmonary Arterial Hypertension

In this study, the effects of kettlebell exercise training on functional capacity, dyspnea and activities of daily living in patients diagnosed with Pulmonary Arterial Hypertension (PAH) will be

  • 0 views
  • 01 Jul, 2022
  • 1 location
TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH (TYEGER)

Pulmonary arterial hypertension (PAH) is a disease characterized by elevated pressures in the blood vessels of the lungs that is not caused by another disease processes. More specifically, it is

pulmonary arterial pressure
vascular disease
right heart catheterization
hpah
left ventricular end-diastolic pressure
  • 0 views
  • 23 Mar, 2022
  • 1 location
Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension (FONCE-HTAP)

Pulmonary Arterial Hypertension is characterized by a progressive increase in pulmonary vascular resistance inducing shortness of breath and exercise intolerance. We aim to correlate cardiac

hypertension
  • 7 views
  • 23 Mar, 2022
  • 9 locations
Effect of CS1 in Subjects With Pulmonary Arterial Hypertension

This is a Phase 2, parallel group study to evaluate the safety, tolerability, PK, and exploratory efficacy of 3 doses of CS1 in the treatment of PAH using the CardioMEMS HF System to obtain

  • 0 views
  • 25 May, 2022
  • 1 location
Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study (VIPAH-PRN 2B)

pulmonary arterial hypertension (PAH).

exercise test
vasodilator
epoprostenol
connective tissue disease
immunodeficiency
  • 0 views
  • 23 Apr, 2022
  • 5 locations
A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension

A Randomized, Placebo-Controlled, Double-blind, Dose Escalation Study to Assess Safety, Efficacy and Pharmacokinetics of GMA301 Injection in Subjects with Pulmonary Arterial Hypertension

connective tissue disease
walk tests
hypertension
pulmonary arterial pressure
endothelin receptor antagonist
  • 0 views
  • 25 Mar, 2022
  • 5 locations